DX-2647 is a human monoclonal antibody that targets insulin-like growth factor-II (IGF-II), exhibiting potent anti-tumor and anti-proliferative properties. This antibody is specifically designed to bind to IGF-II, thereby inhibiting its interaction with the insulin-like growth factor 1 receptor (IGF-1R) and the insulin receptor (IR), which are critical pathways in cancer cell proliferation and survival. DX-2647 offers a promising therapeutic strategy for the treatment of cancers characterized by elevated levels of IGF-II.
DX-2647 is a human monoclonal antibody that targets insulin-like growth factor-II (IGF-II), exhibiting potent anti-tumor and anti-proliferative properties. This antibody is specifically designed to bind to IGF-II, thereby inhibiting its interaction with the insulin-like growth factor 1 receptor (IGF-1R) and the insulin receptor (IR), which are critical pathways in cancer cell proliferation and survival. DX-2647 offers a promising therapeutic strategy for the treatment of cancers characterized by elevated levels of IGF-II.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
